Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Free Tissue Flaps | 6 | 2022 | 67 | 1.300 |
Why?
|
Surgical Flaps | 6 | 2018 | 120 | 1.150 |
Why?
|
Pharyngeal Diseases | 1 | 2021 | 21 | 0.760 |
Why?
|
Scapula | 1 | 2021 | 36 | 0.760 |
Why?
|
Head and Neck Neoplasms | 6 | 2022 | 561 | 0.700 |
Why?
|
Transplant Donor Site | 1 | 2012 | 3 | 0.430 |
Why?
|
Negative-Pressure Wound Therapy | 1 | 2012 | 9 | 0.420 |
Why?
|
Wound Healing | 1 | 2012 | 260 | 0.360 |
Why?
|
Jehovah's Witnesses | 1 | 2008 | 5 | 0.310 |
Why?
|
Deglutition | 4 | 2019 | 221 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2021 | 629 | 0.300 |
Why?
|
Oropharyngeal Neoplasms | 2 | 2006 | 94 | 0.270 |
Why?
|
Retrospective Studies | 8 | 2022 | 7277 | 0.240 |
Why?
|
Postoperative Complications | 5 | 2022 | 1615 | 0.230 |
Why?
|
Forearm | 1 | 2003 | 25 | 0.230 |
Why?
|
Tracheotomy | 1 | 2003 | 17 | 0.220 |
Why?
|
Tissue and Organ Harvesting | 1 | 2003 | 49 | 0.220 |
Why?
|
Aged | 11 | 2021 | 14862 | 0.210 |
Why?
|
Middle Aged | 12 | 2021 | 21147 | 0.210 |
Why?
|
Neck | 3 | 2022 | 62 | 0.210 |
Why?
|
Mouth Neoplasms | 2 | 2021 | 206 | 0.200 |
Why?
|
Programmed Cell Death 1 Receptor | 1 | 2021 | 87 | 0.190 |
Why?
|
Tongue Neoplasms | 2 | 2019 | 29 | 0.180 |
Why?
|
Vascularized Composite Allotransplantation | 1 | 2019 | 17 | 0.170 |
Why?
|
Mouth | 1 | 2019 | 64 | 0.170 |
Why?
|
Gastrostomy | 2 | 2018 | 110 | 0.170 |
Why?
|
Female | 13 | 2021 | 38074 | 0.160 |
Why?
|
Male | 12 | 2021 | 37321 | 0.160 |
Why?
|
Body Image | 1 | 2020 | 100 | 0.160 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 446 | 0.160 |
Why?
|
Laryngectomy | 1 | 2018 | 30 | 0.160 |
Why?
|
Laryngeal Neoplasms | 1 | 2018 | 47 | 0.160 |
Why?
|
Salvage Therapy | 1 | 2018 | 82 | 0.160 |
Why?
|
Length of Stay | 1 | 2021 | 780 | 0.150 |
Why?
|
Humans | 16 | 2022 | 68618 | 0.140 |
Why?
|
Early Goal-Directed Therapy | 1 | 2016 | 6 | 0.130 |
Why?
|
Deglutition Disorders | 1 | 2018 | 297 | 0.120 |
Why?
|
Treatment Outcome | 6 | 2021 | 7029 | 0.120 |
Why?
|
Head | 1 | 2012 | 59 | 0.100 |
Why?
|
Enteral Nutrition | 3 | 2018 | 157 | 0.100 |
Why?
|
Quality of Life | 1 | 2020 | 1515 | 0.100 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 951 | 0.080 |
Why?
|
Time Factors | 3 | 2020 | 4655 | 0.080 |
Why?
|
Carotid Artery, External | 1 | 2008 | 5 | 0.080 |
Why?
|
Ferrous Compounds | 1 | 2008 | 18 | 0.080 |
Why?
|
Hematocrit | 1 | 2008 | 70 | 0.080 |
Why?
|
Microsurgery | 1 | 2008 | 46 | 0.080 |
Why?
|
Erythropoietin | 1 | 2008 | 96 | 0.070 |
Why?
|
Perioperative Care | 1 | 2008 | 100 | 0.070 |
Why?
|
Preoperative Care | 1 | 2008 | 275 | 0.070 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 150 | 0.070 |
Why?
|
Adult | 6 | 2020 | 21403 | 0.070 |
Why?
|
Adenocarcinoma | 1 | 2008 | 475 | 0.060 |
Why?
|
Follow-Up Studies | 3 | 2019 | 3259 | 0.060 |
Why?
|
Cohort Studies | 2 | 2021 | 2358 | 0.060 |
Why?
|
Prognosis | 2 | 2019 | 2093 | 0.060 |
Why?
|
Supination | 1 | 2003 | 2 | 0.060 |
Why?
|
Pronation | 1 | 2003 | 2 | 0.060 |
Why?
|
Wrist | 1 | 2003 | 24 | 0.060 |
Why?
|
Arm | 1 | 2003 | 59 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2021 | 800 | 0.060 |
Why?
|
Oral Surgical Procedures | 1 | 2003 | 15 | 0.050 |
Why?
|
Range of Motion, Articular | 1 | 2003 | 139 | 0.050 |
Why?
|
Postoperative Period | 1 | 2003 | 238 | 0.050 |
Why?
|
Nose | 1 | 2003 | 36 | 0.050 |
Why?
|
Eating | 1 | 2003 | 119 | 0.050 |
Why?
|
Rhinoplasty | 1 | 2003 | 27 | 0.050 |
Why?
|
Prospective Studies | 2 | 2020 | 3705 | 0.050 |
Why?
|
Cleft Lip | 1 | 2003 | 33 | 0.050 |
Why?
|
Tissue Donors | 1 | 2003 | 195 | 0.050 |
Why?
|
Activities of Daily Living | 1 | 2003 | 319 | 0.050 |
Why?
|
Neoadjuvant Therapy | 1 | 2021 | 104 | 0.050 |
Why?
|
Calcinosis | 1 | 2002 | 241 | 0.050 |
Why?
|
Antineoplastic Agents, Immunological | 1 | 2021 | 66 | 0.050 |
Why?
|
Feeding Methods | 1 | 2019 | 17 | 0.040 |
Why?
|
Survival Analysis | 1 | 2021 | 714 | 0.040 |
Why?
|
Composite Tissue Allografts | 1 | 2019 | 8 | 0.040 |
Why?
|
Glossectomy | 1 | 2019 | 9 | 0.040 |
Why?
|
Patient Reported Outcome Measures | 1 | 2020 | 114 | 0.040 |
Why?
|
Confidence Intervals | 1 | 2018 | 242 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 756 | 0.040 |
Why?
|
Odds Ratio | 1 | 2018 | 880 | 0.030 |
Why?
|
Diet | 1 | 2019 | 514 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2016 | 344 | 0.030 |
Why?
|
Hemodynamics | 1 | 2016 | 705 | 0.030 |
Why?
|
Risk Assessment | 1 | 2018 | 2007 | 0.030 |
Why?
|
Adolescent | 1 | 2020 | 8912 | 0.020 |
Why?
|
Tonsillar Neoplasms | 1 | 2006 | 7 | 0.020 |
Why?
|
Parenteral Nutrition | 1 | 2006 | 39 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2006 | 129 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2006 | 125 | 0.020 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2006 | 125 | 0.020 |
Why?
|
Facial Muscles | 1 | 2003 | 11 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2006 | 4848 | 0.010 |
Why?
|